Mednet Logo

How do you counsel patients with RA stable on csDMARDs on whether to attempt tapering or not?

While remission rates after lowering or discontinuing therapy are lower, there is still a population of patients who do not require full-dose therapy to remain in remission. Do you generally encourage patients to attempt taper after a period of stability?
Community PollStarted

Do you attempt to taper csDMARD therapy in patients in sustained remission?

105 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet Member
Mednet MemberInvited Expert
Rheumatology · University of Colorado Anschutz Medical Campus
Answered on

It is important to recognize that this counseling is highly individualized and that factors such as risks of medication toxicity, age, comorbidities and disease severity all play a part. However, several studies have demonstrated a significantly increased risk of RA flares and radiographic progressi...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Rheumatology · Washington University Physicians
Answered on

This is an important discussion with patients as an estimated 15% of patients in remission self-discontinue therapy with unpredictable morbidity and optimally trialed with supervision/shared decision-making. In RA patients within 3 years of their initial diagnosis, I raise this issue after they have...

Join for free or sign in to see the full answer